Short Takes Speakers

Short Takes Speakers


“Solving the Payer Problem: Why most companies fall short, and putting forward a roadmap for getting it right—leading to larger revenue streams, larger partnering deals, and higher investor ROI”

David Balekdjian, CEO, The Bruckner Group



“Human Biospecimens and Translational Research —Past, Present, Future”

Thomas Bell, Director of Scientific Services, NDRI



“Update on the IPO Bubble – Has it Burst?”

John Carroll, Editor-in-Chief, FierceBiotech


Genevieve Dion-01

“Belly Band”

Genevieve Dion, Director of the Shima Seiki Haute Tech Lab at ExCITe, Drexel University


Jenny Filbey-01

“PharmaDirections – Grant Winners Announced”

Jenny Filbey, President, New Perspectives



“The Scope of 3D Printing”

Randy Haluck, Professor & Chief of the Division of Minimally Invasive Surgery and Bariatrics, Vice Chair in Surgery for Technology and Innovation, Penn State’s Hershey Medical Center.


Hogan_J_358_HS Color

“The Changing FDA Regulatory Landscape for Medical Devices and Diagnostics: Challenges and Opportunities”

Janice Hogan, Partner, Hogan Lovells



eric king - square-02

“Why does Amazon know me better than my own doctor?”

Eric King, Founder & CEO, Grand Round Table




“Off-Label First Amendment Court Rulings – What’s Next?”

Daniel Kracov, Partner & Chair, FDA & Healthcare Practice Group, Arnold & Porter



Sharon Kreuger-01

“It Takes a Village to Raise an Idea – How Academic Proof of Concept Funds Are Helping”

Sharon Krueger, Director, Innovation Grants & Relationships, University of Virginia



Tim Kurzweg-01

“Belly Band”

Tim Kurzweg, Associate Professor, Associate Department Head for Undergraduate Affairs, Director of Bachelor of Science in Engineering Program, Drexel University



k moch - square-01

“The Ethical Challenges of Compassionate Use in the Era of Social Media.”

Kenneth Moch, Former President & CEO, Chimerix, Inc.



Owen Montgomery-01

“Belly Band”

Owen Montgomery, Chairman, Drexel University – Department of Ob/Gyn



Chris Morrison-01

“PharmaDirections – Grant Winners Announced”

Chris Morrison, VP of Business Development, PharmaDirections




“SBIR as a source of non-traditional funding.”

Maureen Mulvihill, Ph.D., President and CEO, Actuated Medical



Mike Patterson-01

“NSF I-Corps Funding: Commercialization Support Coming Soon to a Biotech Near You”

Mike Patterson, CEO, Graphene Frontiers



purcell square

“Alternative Sourcing of Financing in the Biotech Industry.”

Dennis Purcell, Senior Managing Partner, Aisling Capital




“Ebola Update.”

Julia Sammons, Medical Director for Infection Prevention and Control, CHOP




“Preparing for Due Diligence and Exit.”

Steve Tullman, Managing Partner, NeXeption




“Innovation in minimally invasive cancer therapies: The past, current, and future of ablation technology.”

Steve Wagner, MD, Interventional Radiologist, Eastern Regional Medical Center